Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Tumor Suppressor Role of INPP4B in Chemoresistant Retinoblastoma.
J Oncol. 2023 Mar 8;2023:2270097. doi: 10.1155/2023/2270097. eCollection 2023.
J Oncol. 2023.
PMID: 36993823
Free PMC article.
ADAM10 and ADAM17-Novel Players in Retinoblastoma Carcinogenesis.
Van Meenen D, Doege A, Alefeld E, Haase A, Beier M, Kiefer T, Biewald E, Metz K, Dräger O, Busch MA, Dünker N.
Van Meenen D, et al.
Int J Mol Sci. 2022 Oct 20;23(20):12621. doi: 10.3390/ijms232012621.
Int J Mol Sci. 2022.
PMID: 36293469
Free PMC article.
Item in Clipboard
New retinoblastoma (RB) drug delivery approaches: anti-tumor effect of atrial natriuretic peptide (ANP)-conjugated hyaluronic-acid-coated gold nanoparticles for intraocular treatment of chemoresistant RB.
Haase A, Miroschnikov N, Klein S, Doege A, Dünker N, Van Meenen D, Junker A, Göpferich A, Apaolaza PS, Busch MA.
Haase A, et al. Among authors: van meenen d.
Mol Oncol. 2024 Apr;18(4):832-849. doi: 10.1002/1878-0261.13587. Epub 2024 Jan 12.
Mol Oncol. 2024.
PMID: 38217258
Free PMC article.
Item in Clipboard
Cite
Cite